Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$543K Buy
3,358
+1,245
+59% +$200K 0.04% 512
2021
Q3
$315K Buy
2,113
+60
+3% +$12.5K 0.02% 639
2021
Q2
$503K Buy
2,053
+417
+25% +$109K 0.04% 465
2021
Q1
$433K Buy
1,636
+66
+4% +$18.6K 0.04% 475
2020
Q4
$461K Buy
1,570
+399
+34% +$102K 0.04% 397
2020
Q3
$277K Buy
1,171
+137
+13% +$31.1K 0.03% 522
2020
Q2
$205K Buy
1,034
+65
+7% +$12.1K 0.02% 531
2020
Q1
$178K Buy
969
+69
+8% +$12.3K 0.02% 576
2019
Q4
$150K Buy
900
+90
+11% +$13.4K 0.02% 792
2019
Q3
$106K Buy
810
+134
+20% +$17.4K 0.01% 886
2019
Q2
$82K Buy
+676
New +$80.2K 0.01% 982

Other funds holding AMED

Next Financial Group's AMED Position: Q4 2021 in Review

Next Financial Group increased its Amedisys (AMED) stake by 59% in Q4 2021, buying an estimated $200K and bringing the position to 3,358 shares worth $543K. The position accounts for 0.04% of the portfolio, ranked #512.

Next Financial Group first reported a position in AMED in Q2 2019 and has held it in 11 quarters since. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Next Financial Group held 3,358 shares of Amedisys worth $543K as of Q4 2021.
  • Next Financial Group bought 1,245 Amedisys shares in Q4 2021, an estimated $200K.
  • Amedisys made up 0.04% of Next Financial Group's portfolio in Q4 2021, its #512 holding.
  • Next Financial Group first reported a position in Amedisys in Q2 2019 and has held it in 11 quarters since.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.